160 related articles for article (PubMed ID: 15020068)
1. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Palaszynski KM; Liu H; Loo KK; Voskuhl RR
J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
[TBL] [Abstract][Full Text] [Related]
4. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
[TBL] [Abstract][Full Text] [Related]
6. Methylthioadenosine reverses brain autoimmune disease.
Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
Genoud S; Maricic I; Kumar V; Gage FH
J Neuroimmunol; 2005 Nov; 168(1-2):40-5. PubMed ID: 16120466
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
[TBL] [Abstract][Full Text] [Related]
9. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
Elloso MM; Phiel K; Henderson RA; Harris HA; Adelman SJ
J Endocrinol; 2005 May; 185(2):243-52. PubMed ID: 15845917
[TBL] [Abstract][Full Text] [Related]
10. A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Li Y; Ventura ES; Gran B; Rostami A
J Neuroimmunol; 2005 Apr; 161(1-2):101-12. PubMed ID: 15748949
[TBL] [Abstract][Full Text] [Related]
11. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
12. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
13. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
14. Quinpramine is a novel compound effective in ameliorating brain autoimmune disease.
Singh MP; Meyer zu Hörste G; Hu W; Mausberg AK; Cravens PD; Eagar T; Löber S; Klingenstein R; Gmeiner P; Korth C; Kieseier BC; Stüve O
Exp Neurol; 2009 Feb; 215(2):397-400. PubMed ID: 18996373
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Gold SM; Sasidhar MV; Morales LB; Du S; Sicotte NL; Tiwari-Woodruff SK; Voskuhl RR
Lab Invest; 2009 Oct; 89(10):1076-83. PubMed ID: 19668239
[TBL] [Abstract][Full Text] [Related]
16. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
17. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Offner H
J Neurosci Res; 2004 Dec; 78(5):603-24. PubMed ID: 15515048
[TBL] [Abstract][Full Text] [Related]
18. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
Kim S; Liva SM; Dalal MA; Verity MA; Voskuhl RR
Neurology; 1999 Apr; 52(6):1230-8. PubMed ID: 10214749
[TBL] [Abstract][Full Text] [Related]
19. Transcription of estrogen receptor alpha and beta in mouse cerebral cortex: effect of age, sex, 17beta-estradiol and testosterone.
Thakur MK; Sharma PK
Neurochem Int; 2007 Jan; 50(2):314-21. PubMed ID: 17113197
[TBL] [Abstract][Full Text] [Related]
20. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
Stygar D; Westlund P; Eriksson H; Sahlin L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
